会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 34. 发明授权
    • Nouveaux dérivés de omega-mercaptopropanamide et de ses homologues, leur procédé de préparation, leur application comme médicaments, les compositions les renfermant et les nouveaux intermédiaires obtenus
    • EP0115997B1
    • 1987-07-22
    • EP84400216.2
    • 1984-02-01
    • ROUSSEL-UCLAF
    • Vevert, Jean-Paul F.Delevallée, Françoise F.Deraedt, Roger F.
    • C07C149/23C07C149/41C07C153/09C07D213/75C07D235/30C07D277/00A61K31/16A61K31/265A61K31/41A61K31/44
    • C07D213/75C07D235/30C07D277/18C07D277/46C07D277/82
    • For the Contracting States : BE CH DE FR GB IT LI LU NL SE 1. Compounds with the formula (I) : see diagramm : EP0115997,P26,F1 in which R1 represents a hydrogen atom or a see diagramm : EP0115997,P26,F2 radical, R'1 being an alkyl radical containing from 1 to 5 carbon atoms or an aryl radical possibly substituted by a hydroxy radical, an alkyl radical containing from 1 to 5 carbon atoms, an alkoxy radical containing from 1 to 5 carbon atoms, a nitro radical or a halogen atom, n represents a whole number able to vary from 1 to 5, R2 represents a hydrogen atom, an alkyl radical containing from 1 to 5 carbon atoms, an aryl or arylalkyl radical containing from 6 to 15 carbon atoms, possibly substituted by an alkyl radical containing from 1 to 5 carbon atoms, an alkoxy radical containing from 1 to 5 carbon atoms, a hydroxyl radical, a halogen atom or a trifluoromethyl radical, R3 represents a heterocyclic radical chosen from the following radicals :- thiazolyl, 4,5-dihydrothiazolyl, pyridinyl, oxazolyl, isoxazolyl, imidazolyl, pyrimidyl, tetrazolyl, benzimidazolyl, benzothiazolyl or benzoxazolyl, possibly substituted by an alkyl radical containing from 1 to 5 carbon atoms or R3 represents a hydrogen atom, a phenyl radical possibly substituted by one or more radicals chosen from the group constituted by alkyl radicals containing from 1 to 5 carbon atoms, alkoxy radicals containing from 1 to 5 carbon atoms, a hydroxyl radical, a nitro radical, halogen atoms, a trifluoromethyl radical, a carboxymethyl radical, alkoxy carbonylmethyl radicals in which the alkoxy radical contains from 1 to 5 carbon atoms, aralkyloxy radicals containing from 7 to 15 carbon atoms and the radicals : see diagramm : EP0115997,P27,F3 in which X and X', identical or different, represent a hydrogen atom or an alkyl radical containing from 1 to 5 carbon atoms, R3 however not being able to represent a phenyl radical, not substituted or substituted by one or more radicals chosen from the group constituted by alkyl radicals containing from 1 to 5 carbon atoms, alkoxy radicals containing from 1 to 5 carbon atoms, and halogen atoms, when R2 represents a hydrogen atom and when n is equal to 1 or 2, and R3 not being able to represent a phenyl radical substituted by a carboxymethyl radical when R2 represents a methyl radical and when n is equal to 1, as well as their addition salts with acids and bases. For the Contracting State : AT 1. Process for preparing compounds with the formula (I) : see diagramm : EP0115997,P28,F1 in which R1 represents a hydrogen atom or a see diagramm : EP0115997,P28,F2 radical, R'1 being an alkyl radical containing from 1 to 5 carbon atoms or an aryl radical possibly substituted by a hydroxy radical, an alkyl radical containing from 1 to 5 carbon atoms, an alkoxy radical containing from 1 to 5 carbon atoms, a nitro radical or a halogen atom, n represents a whole number able to vary from 1 to 5, R2 represents a hydrogen atom, an alkyl radical containing from 1 to 5 carbon atoms, an aryl or arylalkyl radical containing from 6 to 15 carbon atoms, possibly substituted by an alkyl radical containing from 1 to 5 carbon atoms, an alkoxy radical containing from 1 to 5 carbon atoms, a hydroxyl radical, a halogen atom or a trifluoromethyl radical, R3 represents a heterocyclic radical chosen from the following radicals :- thiazolyl, 4,5-dihydrothiazolyl, pyridinyl, oxazolyl, isoxazolyl, imidazolyl, pyrimidyl, tetrazolyl, benzimidazolyl, benzothiazolyl or benzoxazolyl, possibly substituted by an alkyl radical containing from 1 to 5 carbon atoms or R3 represents a hydrogen atom, a phenyl radical possibly substituted by one or more radicals chosen from the group constituted by alkyl radicals containing from 1 to 5 carbon atoms, alkoxy radicals containing from 1 to 5 carbon atoms, a hydroxyl radical, a nitro radical, halogen atoms, a trifluoromethyl radical, a carboxymethyl radical, alkoxy carbonylmethyl radicals in which the alkoxy radical contains from 1 to 5 carbon atoms, aralkyloxy radicals containing from 7 to 15 carbon atoms and the radicals : see diagramm : EP0115997,P29,F3 in which X and X', identical or different, represent a hydrogen atom or an alkyl radical containing from 1 to 5 carbon atoms, R3 however not being able to represent a phenyl radical, not substituted or substituted by one or more radicals chosen from the group constituted by alkyl radicals containing from 1 to 5 carbon atoms, alkoxy radicals containing from 1 to 5 carbon atoms, and halogen atoms, when R2 represents a hydrogen atom and when n is equal to 1 or 2, and R3 not being able to represent a phenyl radical substituted by a carboxymethyl radical when R2 represents a methyl radical and when n is equal to 1, as well as their addition salts with acids and bases, characterized in that : - to prepare compounds with the formula (I) in which R1 , R2 and R3 have the previously given significance and in which n=1, as well as their addition salts with acids and bases, and acid with the formula (II) : see diagramm : EP0115997,P29,F4 in which R'1 and R2 have the significances already indicated, or a functional derivative of this acid, is submitted to the action of a product with the formula (III) : H2 N-R3 in which R3 has the significance already indicated, so as to obtain a product with the formula (I) in which : see diagramm : EP0115997,P29,F5 R'1 as well as R2 and R3 have the significances already indicated and in which n=1, which product with the formula (I), if necessary or desired, is saponified, so as to obtain a product with the formula (I) in which R1 represents a hydrogen atom, which products with the formula (I) are submitted, if desired, to the action of a base or an acid so as to form the corresponding salts ; - to prepare compounds with the formula (I) in which R1 , R2 and R3 have the previously given significance and in which n is a whole number varying from 1 to 5, as well as their addition salts with acids and bases, an acid with the formula (IV) : see diagramm : EP0115997,P29,F6 in which X1 is a halogen atom and in which n and R2 have the significances given above, or a functional derivative of this acid, is submitted to the action of a product with the previous formula (III) (NH2 -R3 ), so as to obtain a product with the formula (V) : see diagramm : EP0115997,P29,F7 in which X1 , n, R2 and R3 have the previosu significances, which is submitted to the action of the anion of a thioacid with the formula (VI) : see diagramm : EP0115997,P30,F8 in which R'1 keeps its significance, so as to obtain a product with the formula (I) in which r1 = R'1 see diagramm : EP0115997,P30,F9 n represents a whole number able to vary from 1 to 5 and in which R'1 , R2 and R3 have the significances given above, which product with the formula (I), if necessary or desired, is saponified, so as to obtain a product with the formula (I) in which R1 represents a hydrogen atom, which products with the formula (I) are submitted, if desired, to the action of an acid or of a base so as to form the corresponding salts.
    • 38. 发明公开
    • Antagonists of slow reacting substances of anaphylaxis
    • 慢性反应物质的拮抗作用
    • EP0150118A3
    • 1985-08-28
    • EP85300367
    • 1985-01-18
    • MERCK FROSST CANADA INC.
    • Rokach, JoshuaYoung, Robert N.
    • C07C149/41C07C147/14C07C147/107A61K31/195C07D207/16
    • A61K31/18
    • Compounds having the formula:
      and their pharmaceutically acceptable salts and acid- addition salts, are antagonists of leukotrienes of C 4 , D 4 and E 4 , the slow reacting substance of anaphylaxis. These compounds are useful as anti-asthmatic, anti-allergic, anti-Inflammatory agents and cytoprotective agents. In the formula, each R, independently of the others, is hydrogen, hydroxy, C 1-6 alkyl, C 2-6 alkenyl, trifluoromethyl, C 1-6 alkoxy, mercapto, C 1-6 thioalkyl, phenyl, phenyl substituted by C 1-3 alkyl or by halogen, benzyl, phenethyl, halogen, amino, N(R 3 ) 2 , COOR 3 , CH 2 0R 3 , formyl, cyano, trifluoromethylthio or nitro;
      each R', independently of the others, R 3 or R 4 , or R' and R' together are an oxo or methylene group; each R 1 , independently of the others, is hydrogen or C 1-4 alkyl; R 2 is C 1-6 alkyl or C 3-6 alkenyl; each R 3 , independently of any others, is hydrogen or C 1-6 alkyl; R 4 is hydrogen, C 1-6 alkyl or C 1-6 alkoxy; R 6 is hydrogen, C 1-6 alkyl, R 3 CO- or R 3 0CH 2 -; each R 6 , independently of any others, is R 3 or is such that HNR 6 -(CR 6 R 6 )-COOR 3 is an amino acid or amino acid ester; each of X 1 and X 2 , independently of the other, is oxygen, sulfur, sulfoxide, sulfone;
      Z is 0, S or NR 3 ; each n, independently of any others, is 0 or an integer from 1 to 6.
    • 39. 发明公开
    • Antagonists of slow reacting substances of anaphylaxis
    • 反刍动物on am den den den den ie ie ie(((。。。。。。。。。。。
    • EP0150118A2
    • 1985-07-31
    • EP85300367.1
    • 1985-01-18
    • MERCK FROSST CANADA INC.
    • Rokach, JoshuaYoung, Robert N.
    • C07C149/41C07C147/14C07C147/107A61K31/195C07D207/16
    • A61K31/18
    • Compounds having the formula:
      and their pharmaceutically acceptable salts and acid- addition salts, are antagonists of leukotrienes of C 4 , D 4 and E 4 , the slow reacting substance of anaphylaxis. These compounds are useful as anti-asthmatic, anti-allergic, anti-Inflammatory agents and cytoprotective agents.
      In the formula, each R, independently of the others, is hydrogen, hydroxy, C 1-6 alkyl, C 2-6 alkenyl, trifluoromethyl, C 1-6 alkoxy, mercapto, C 1-6 thioalkyl, phenyl, phenyl substituted by C 1-3 alkyl or by halogen, benzyl, phenethyl, halogen, amino, N(R 3 ) 2 , COOR 3 , CH 2 0R 3 , formyl, cyano, trifluoromethylthio or nitro;

      each R', independently of the others, R 3 or R 4 , or R' and R' together are an oxo or methylene group;
      each R 1 , independently of the others, is hydrogen or C 1-4 alkyl;
      R 2 is C 1-6 alkyl or C 3-6 alkenyl;
      each R 3 , independently of any others, is hydrogen or C 1-6 alkyl;
      R 4 is hydrogen, C 1-6 alkyl or C 1-6 alkoxy;
      R 6 is hydrogen, C 1-6 alkyl, R 3 CO- or R 3 0CH 2 -;
      each R 6 , independently of any others, is R 3 or is such that HNR 6 -(CR 6 R 6 )-COOR 3 is an amino acid or amino acid ester;
      each of X 1 and X 2 , independently of the other, is oxygen, sulfur, sulfoxide, sulfone;

      Z is 0, S or NR 3 ;
      each n, independently of any others, is 0 or an integer from 1 to 6.
    • 具有下式的化合物及其药学上可接受的盐和酸加成盐是C4,D4和E4的白三烯,慢性反应物质的过敏反应的拮抗剂。 这些化合物可用作抗哮喘,抗过敏,抗炎剂和细胞保护剂。 在该式中,各R独立地为氢,羟基,C 1-6烷基,C 2-6烯基,三氟甲基,C 1-6烷氧基,巯基,C 1-6硫烷基,苯基,被C 1-3烷基取代的苯基 或卤素,苄基,苯乙基,卤素,氨基,N(R3)2,COOR3,CH2OR3,甲酰基,氰基,三氟甲硫基或硝基; 每个R min独立地为R3或R4,或Rmin和Rmin一起为氧代或亚甲基; 每个R 1独立地为氢或C 1-4烷基; R2是C1-6烷基或C3-6烯基; 每个R 3,独立于任何其它的是氢或C 1-6烷基; R4是氢,C1-6烷基或C1-6烷氧基; R5是氢,C1-6烷基,R3CO-或R3OCH2-; 每个R 6独立地为R 3,或者使得HNR 6 - (CR 6 R 6)-COOR 3是氨基酸或氨基酸酯; X1和X2各自独立地为氧,硫,亚砜,砜; @ = NR3; N - @ - R4; N-CN; 或NCONHR3; Z是O,S或NR 3; 每个n独立于任何其它,为O或1至6的整数。